EULAR 2026 Daily Podcast Day 4c Save
Guselkumab Delivers Across the PsA Disease Spectrum: APEX Trial
RA BRIDGE and RA BRANCH trials: Baricitinib and VTE Risk
Improving Referrals for Inflammatory Arthritis"
Combination Therapy: Off the Shelf Allogenic NK and Rituximab in Rheumatic Disease



If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.